Kynam Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History

Kynam Capital Management’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,820,954	Closed	-$36.7M	–	36
2026 Q1	$36.7M	Buy	1,820,954 +10,000	+0.6%	+$161K	2.26%	13
2025 Q4	$29.2M	Buy	1,810,954 +1,204,783	+199%	+$16M	1.87%	17
2025 Q3	$7.38M	Buy	+606,171	New	+$8.38M	0.55%	27

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Kynam Capital Management's KALV Position: Q2 2026 in Review

Kynam Capital Management sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 1,820,954 shares — an estimated $36.7M sold.

Kynam Capital Management first reported a position in KALV in Q3 2025 and held it in 3 quarters. The position peaked at $36.7M in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Kynam Capital Management reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Kynam Capital Management sold 1,820,954 KalVista Pharmaceuticals shares in Q2 2026, an estimated $36.7M.
Kynam Capital Management first reported a position in KalVista Pharmaceuticals in Q3 2025 and held it in 3 quarters.
Kynam Capital Management's KalVista Pharmaceuticals position peaked at $36.7M in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Kynam Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.